Book contents
- Early PregnancySecond Edition
- Early Pregnancy
- Copyright page
- Contents
- Contributors
- Preface to the Second Edition
- 1 Endometrial Development and Gene Expression
- 2 Decidualization and Recurrent Miscarriage
- 3 Hemochorial Development
- 4 Implantation
- 5 Early Placental Development and Disorders
- 6 Meiosis and the Embryo
- 7 Environmental Toxicants and Reproduction
- 8 Thyroid Physiology and Early Pregnancy
- 9 Müllerian Duct Development
- 10 Candidate Genes for Pregnancy Loss
- 11 Antiphospholipid Antibodies and Reproduction
- 12 Defining Recurrent Pregnancy Loss
- 13 Guidelines on the Diagnosis and Management of Miscarriage
- 14 The Value of Early Pregnancy Units
- 15 Investigation of Recurrent Miscarriage
- 16 Designing and Optimizing Treatment Trials for Recurrent Pregnancy Loss
- 17 Risk Factors for First Trimester Miscarriage
- 18 Tubal Ectopic Pregnancy and Pregnancy of Unknown Location
- 19 Non-Tubal Ectopic Pregnancy
- 20 Ultrasound to Diagnose and Predict Early Pregnancy Outcome
- 21 Three-Dimensional Virtual Reality in Early Pregnancy
- 22 Molar Pregnancy
- 23 Role of Miscarriage Evaluation
- 24 Inherited Thrombophilia and Early Pregnancy
- 25 Immunotherapy and Recurrent Pregnancy Loss
- 26 Progesterone Use in Early Pregnancy
- 27 Vanishing Twin Syndrome and Long-Term Outcome
- 28 Obesity and Early Pregnancy
- 29 Chronic Endometritis and Reproduction
- 30 Miscarriage after In Vitro Fertilization (IVF)
- 31 HLA Associations and Recurrent Pregnancy Loss
- 32 Midtrimester Pregnancy Loss
- Index
- Plate Section (PDF Only)
- References
16 - Designing and Optimizing Treatment Trials for Recurrent Pregnancy Loss
Published online by Cambridge University Press: 16 February 2017
Book contents
- Early PregnancySecond Edition
- Early Pregnancy
- Copyright page
- Contents
- Contributors
- Preface to the Second Edition
- 1 Endometrial Development and Gene Expression
- 2 Decidualization and Recurrent Miscarriage
- 3 Hemochorial Development
- 4 Implantation
- 5 Early Placental Development and Disorders
- 6 Meiosis and the Embryo
- 7 Environmental Toxicants and Reproduction
- 8 Thyroid Physiology and Early Pregnancy
- 9 Müllerian Duct Development
- 10 Candidate Genes for Pregnancy Loss
- 11 Antiphospholipid Antibodies and Reproduction
- 12 Defining Recurrent Pregnancy Loss
- 13 Guidelines on the Diagnosis and Management of Miscarriage
- 14 The Value of Early Pregnancy Units
- 15 Investigation of Recurrent Miscarriage
- 16 Designing and Optimizing Treatment Trials for Recurrent Pregnancy Loss
- 17 Risk Factors for First Trimester Miscarriage
- 18 Tubal Ectopic Pregnancy and Pregnancy of Unknown Location
- 19 Non-Tubal Ectopic Pregnancy
- 20 Ultrasound to Diagnose and Predict Early Pregnancy Outcome
- 21 Three-Dimensional Virtual Reality in Early Pregnancy
- 22 Molar Pregnancy
- 23 Role of Miscarriage Evaluation
- 24 Inherited Thrombophilia and Early Pregnancy
- 25 Immunotherapy and Recurrent Pregnancy Loss
- 26 Progesterone Use in Early Pregnancy
- 27 Vanishing Twin Syndrome and Long-Term Outcome
- 28 Obesity and Early Pregnancy
- 29 Chronic Endometritis and Reproduction
- 30 Miscarriage after In Vitro Fertilization (IVF)
- 31 HLA Associations and Recurrent Pregnancy Loss
- 32 Midtrimester Pregnancy Loss
- Index
- Plate Section (PDF Only)
- References
- Type
- Chapter
- Information
- Early Pregnancy , pp. 159 - 168Publisher: Cambridge University PressPrint publication year: 2017
References
Tversky, A. and Kahneman, D., Judgment under uncertainty: heuristics and biases. Science, 1974. 185(4157): 1124–31.CrossRefGoogle ScholarPubMed
Christiansen, O.B., et al., Evidence-based investigations and treatments of recurrent pregnancy loss. Fertil Steril, 2005. 83(4): 821–39.CrossRefGoogle ScholarPubMed
Stagnaro-Green, A., et al., Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies. JAMA, 1990. 264(11): 1422–25.CrossRefGoogle ScholarPubMed
Mosaddegh, M.H., et al., Treatment of recurrent pregnancy loss by levothyroxine in women with high anti-TPO antibody. Iran J Reprod Med, 2012. 10(4): 373–76.Google Scholar
Group, O.L.o.E.W. The Oxford 2011 Levels of Evidence. Oxford: Oxford Centre for Evidence-Based Medicine; 2011.Google Scholar
Jauniaux, E., et al., Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage. Hum Reprod, 2006. 21(9): 2216–22.CrossRefGoogle ScholarPubMed
Atkins, D., et al., Grading quality of evidence and strength of recommendations. BMJ, 2004. 328(7454): 1490.Google ScholarPubMed
Kaandorp, S.P., et al., Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. N Engl J Med, 2010. 362(17): 1586–96.CrossRefGoogle ScholarPubMed
Jelsma, J.G., et al., DALI: Vitamin D and lifestyle intervention for gestational diabetes mellitus (GDM) prevention: an European multicentre, randomised trial – study protocol. BMC Pregnancy Childbirth, 2013. 13: 142.CrossRefGoogle ScholarPubMed
Bhattacharya, S. and Mollison, J., Gynaecology and infertility. In Textbook of Clinical Trials, ed. Machin, D, Day, S, Green, S. John Wiley & Sons, Ltd; 2004, pp. 337–57.Google Scholar
Torgerson, D.J. and Sibbald, B., Understanding controlled trials. What is a patient preference trial? BMJ, 1998. 316(7128): 360.CrossRefGoogle ScholarPubMed
Gynaecology, D.S.o.O.a., Guideline: recurrent miscarriage. NVOG. Netherlands: NVOG; 2007.Google Scholar
Glasziou, P., Irwin, L., Bain, C., Colditz, G., Systematic Reviews in Health Care: A Practical Guide. Cambridge: Cambridge University Press; 2001, pp. 3–138.CrossRefGoogle Scholar
de Jong, P.G., et al., Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia. Cochrane Database Syst Rev, 2014. 7: CD004734.Google Scholar
Wong, L.F., Porter, T.F., and Scott, J.R., Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev, 2014. 10: CD000112.Google Scholar
Haas, D.M. and Ramsey, P.S., Progestogen for preventing miscarriage. Cochrane Database Syst Rev, 2013. 10: CD003511.Google Scholar
Morley, L.C., Simpson, N., and Tang, T., Human chorionic gonadotrophin (hCG) for preventing miscarriage. Cochrane Database Syst Rev, 2013. 1: CD008611.Google Scholar
Yang, G.Y., et al., Chinese herbal medicine for the treatment of recurrent miscarriage: a systematic review of randomized clinical trials. BMC Complement Altern Med, 2013. 13: 320.CrossRefGoogle ScholarPubMed
Kowalik, C.R., et al., Metroplasty versus expectant management for women with recurrent miscarriage and a septate uterus. Cochrane Database Syst Rev, 2011(6): CD008576.Google Scholar
Empson, M., et al., Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev, 2005(2): CD002859.Google Scholar
Clifford, K., Rai, R., and Regan, L., Future pregnancy outcome in unexplained recurrent first trimester miscarriage. Hum Reprod, 1997. 12(2): 387–89.CrossRefGoogle ScholarPubMed
Practice Committee of the American Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss. Fertil Steril, 2008. 90(5 Suppl): S60.CrossRefGoogle Scholar
Kolte, A.M., et al., Non-visualized pregnancy losses are prognostically important for unexplained recurrent miscarriage. Hum Reprod, 2014. 29(5): 931–37.CrossRefGoogle ScholarPubMed
Mansour Ghanaie, M., et al., Effects of varicocele repair on spontaneous first trimester miscarriage: a randomized clinical trial. Urol J, 2012. 9(2): 505–13.Google ScholarPubMed
Christiansen, O., et al., Intravenous immunoglobulin treatment for secondary recurrent miscarriage: a randomised, double-blind, placebo-controlled trial. BJOG, 2015. 122(4): 500–08.CrossRefGoogle ScholarPubMed
Badawy, A.M., et al., Low-molecular weight heparin in patients with recurrent early miscarriages of unknown aetiology. J Obstet Gynaecol, 2008. 28(3): 280–84.CrossRefGoogle ScholarPubMed
Braakhekke, M., et al., Ongoing pregnancy qualifies best as the primary outcome measure of choice in trials in reproductive medicine: an opinion paper. Fertil Steril, 2014. 101(5): 1203–04.CrossRefGoogle Scholar
Gomaa, M.F., et al., Combined oral prednisolone and heparin versus heparin: the effect on peripheral NK cells and clinical outcome in patients with unexplained recurrent miscarriage. A double-blind placebo randomized controlled trial. Arch Gynecol Obstet, 2014. 290(4): 757–62.CrossRefGoogle ScholarPubMed
Caldwell, P.H., et al., Strategies for increasing recruitment to randomised controlled trials: systematic review. PLoS Med, 2010. 7(11): e1000368.CrossRefGoogle ScholarPubMed
Lund, M., et al., Prognosis for live birth in women with recurrent miscarriage: what is the best measure of success? Obstet Gynecol, 2012. 119(1): 37–43.CrossRefGoogle ScholarPubMed
Jadad, A.R. and Enkin, M.W., Bias in randomized controlled trials. In Randomized Controlled Trials: Questions, Answers and Musings. Second edition. Wiley Online Library; 2008, Chapter 3.Google Scholar
Day, S.J. and Altman, D.G., Statistics notes: blinding in clinical trials and other studies. BMJ, 2000. 321(7259): 504.CrossRefGoogle ScholarPubMed
Campbell, M.K., et al., Recruitment to randomised trials: strategies for trial enrollment and participation study. The STEPS study. Health Technol Assess, 2007. 11(48): iii, ix–105.CrossRefGoogle Scholar
Visser, J., et al., Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: a randomised multicentre trial. Thromb Haemost, 2011. 105(2): 295–301.CrossRefGoogle ScholarPubMed
Ellis, P.M., Attitudes towards and participation in randomised clinical trials in oncology: a review of the literature. Ann Oncol, 2000. 11(8): 939–45.CrossRefGoogle ScholarPubMed
Realpe, A., Involving patients in optimizing RCT participant information sheets and exploring patient acceptability of clinical trials. Trials, 2013. 14(1): 71.CrossRefGoogle Scholar
Edwards, P., Questionnaires in clinical trials: guidelines for optimal design and administration. Trials, 2010. 11: 2.CrossRefGoogle ScholarPubMed
Higgings, J.P.T. and Green, S., Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration; 2011.Google Scholar